| 000 | 01243 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514191308.0 | ||
| 264 | 0 | _c20040622 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 024 | 7 |
_a10.1053/j.seminoncol.2004.03.038 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcArthur, Grant | |
| 245 | 0 | 0 |
_aMolecularly targeted treatment for dermatofibrosarcoma protuberans. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cApr 2004 |
||
| 300 |
_a30-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 |
_aDermatofibrosarcoma _xdrug therapy |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptor, Platelet-Derived Growth Factor beta _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 773 | 0 |
_tSeminars in oncology _gvol. 31 _gno. 2 Suppl 6 _gp. 30-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.seminoncol.2004.03.038 _zAvailable from publisher's website |
| 999 |
_c14883591 _d14883591 |
||